Creative biosynthesis mitigates pathogenesis in mdx mice

创造性生物合成减轻 mdx 小鼠的发病机制

• 批准号: 7658764
• 负责人: BRIAN S TSENG
• 金额: $ 12.69万
• 依托单位: MASSACHUSETTS GENERAL HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-08-01 至 2011-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7658764
• 关键词: A Mouse; Advisory Committees; Anabolism; Biochemical; Biochemical Markers; Bioinformatics; Biological Assay; Cell membrane; Childhood; Clinical; Clinical Investigator; Creatine; Creatine Kinase; Development; Developmental Biology; Disease; Doctor of Philosophy; Duchenne muscular dystrophy; Dystrophin; Enzyme Precursors; Enzymes; Exhibits; Extravasation; Fiber; Functional disorder; Gene Mutation; Gene-Modified; Genetic; Goals; Guanidinoacetate N-Methyltransferase; Histology; Histopathology; Homologous Gene; Human; Imaging Techniques; In Situ Hybridization; Internet; K-Series Research Career Programs; Knockout Mice; Lead; Longevity; Magnetic Resonance Imaging; Measures; Medical; Membrane; Mentors; Messenger RNA; Metabolic; Methyltransferase; Mining; Mission; Molecular; Molecular Genetics; Mus; Muscle; Muscle Fibers; Muscle function; Muscular Dystrophies; Mutation; Myopathy; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Neurologist; Pathogenesis; Pathology; Patients; Phenotype; Postdoctoral Fellow; Principal Investigator; Production; Prognostic Marker; Proteins; Protons; Reaction; Research; Research Personnel; Resources; Role; Running; Scientist; Serum; Skeletal Muscle; Technology; Testing; Time; Training; Urine; Utrophin; amidinotransferase; base; boys; career; creatine transporter; fitness; gait examination; graduate student; improved; in vivo; insight; interest; mdx mouse; multidisciplinary; novel; programs; satellite cell; skills

DESCRIPTION (provided by applicant): This proposal describes a 5 year Mentored Clinical Investigator Career Development Award in Muscle Diseases Research as detailed in the NIAMS mission statement. The MD/PhD principal investigator is a board-certified pediatric neurologist. He will now expand upon his scientific skills through a unique integration of interdepartmental resources and establish a scientific niche to construct an academic career. This program will promote the longstanding interest of the PI in Duchenne Muscular Dystrophy (DMD) by expanding into molecular and developmental biology and mouse molecular genetics. Dr. Lee Niswander will mentor the principal investigators scientific development. A Howard Hughes Medical Investigator, Dr. Niswander is a recognized leader in the field of developmental biology and mouse genetics and has trained numerous postdoctoral fellows, graduate students and clinical fellows. In addition, an advisory committee of highly-regarded muscle scientists will provide scientific, clinical and career advice to help the PI develop into an independent investigator. The PI is in an ideal setting to incorporate expertise from diverse resources and utilize multidisciplinary technologies. Research will focuses on the hypothesis of de novo creatine synthesis in dystrophin-deficient mdx mice. The PI has identified guanidineacetate methyltransferase (GAMT), the key enzyme for creatine synthesis as being differentially upregulated at both the mRNA and protein level in mdx skeletal muscle. Using an assortment of biochemical, molecular, cellular and magnetic resonance imaging techniques, the specific aims include: 1) As GAMT is upregulated in mdx mice, the end-product creatine should also be increased. However because of membrane leakage, increased creatine levels may be largely found in urine and serum, not muscle, 2) Determine if AGAT (the precursor enzyme with GAMT required for creatine synthesis), is also upregulated at the mRNA and protein level in mdx muscle, and 3) Determine the phenotype of a double-null GAMTimdx mouse. This will be the first detailed analysis of creatine biosynthesis in the mdx mouse. Objective is to determine if the mdx mouse synthesizes creatine de-novo as an adaptation to mitigate metabolic compromise caused by leaky membranes. Dystrophin is an important protein for normal muscle function. Boys with DMD do not make dystrophin and their muscles weaken over time. The mdx mice do not make dystrophin yet they do not become crippled. These studies may offer important clues that could help with new treatments for boys with DMD.

描述（由申请人提供）：本提案描述了一个为期5年的肌肉疾病研究指导临床研究者职业发展奖，详见NIAMS使命声明。MD/PhD主要研究者是一名委员会认证的儿科神经科医生。他现在将通过独特的跨部门资源整合来扩展自己的科学技能，并建立科学利基来构建学术生涯。该计划将通过扩展到分子和发育生物学以及小鼠分子遗传学来促进PI对杜氏肌营养不良症（DMD）的长期兴趣。Lee Niswander博士将指导主要研究人员的科学发展。Niswander博士是霍华德休斯医学研究员，是发育生物学和小鼠遗传学领域公认的领导者，培养了众多博士后研究员、研究生和临床研究员。此外，一个由备受推崇的肌肉科学家组成的咨询委员会将提供科学，临床和职业建议，以帮助PI发展成为独立的研究者。PI处于理想的环境中，可以整合来自不同资源的专业知识并利用多学科技术。研究将集中在肌营养不良蛋白缺陷mdx小鼠从头肌酸合成的假设。PI已鉴定出肌酸合成的关键酶乙酸胍甲基转移酶（GAMT）在mdx骨骼肌中在mRNA和蛋白质水平上差异上调。使用各种生物化学、分子、细胞和磁共振成像技术，具体目标包括：1）由于GAMT在mdx小鼠中上调，因此终产物肌酸也应增加。然而，由于膜渗漏，增加的肌酸水平可能主要存在于尿液和血清中，而不是肌肉中，2）确定AGAT（肌酸合成所需的具有GAMT的前体酶）是否也在mdx肌肉中在mRNA和蛋白质水平上上调，和3）确定双无效GAMTimdx小鼠的表型。这将是mdx小鼠肌酸生物合成的第一次详细分析。目的是确定mdx小鼠是否重新合成肌酸作为一种适应，以减轻由膜渗漏引起的代谢损害。肌营养不良蛋白是维持正常肌肉功能的重要蛋白质。患有DMD的男孩不会产生肌营养不良蛋白，他们的肌肉会随着时间的推移而减弱。mdx小鼠不产生抗肌萎缩蛋白，但它们不会变成残废。这些研究可能会提供重要的线索，有助于DMD男孩的新治疗。